MD, CHIEF ACCOUNTING OFFICER Zook Brian D acquired 5,058 units of Series A Preference Shares (SEC Form 4)
$LILAK
Cable & Other Pay Television Services
Telecommunications
| FORM 4 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
| |||||||||||||||
| Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). | |||||||||||||||||
| Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. | |||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
(Country) | 2. Issuer Name and Ticker or Trading Symbol
Liberty Latin America Ltd. [ LILA ] | 5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
| |||||||||||||||||||||||||
| 2a. Foreign Trading Symbol
| |||||||||||||||||||||||||||
| 3. Date of Earliest Transaction
(Month/Day/Year) 06/16/2026 | 6. Individual or Joint/Group Filing (Check Applicable Line)
| ||||||||||||||||||||||||||
| 4. If Amendment, Date of Original Filed
(Month/Day/Year) |
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
| Code | V | Amount | (A) or (D) | Price | ||||||
| Series A Preference Shares | 06/16/2026 | J | V | 4,918 | A | $0 | 4,918(1) | D | ||
| Series A Preference Shares | 06/16/2026 | J | V | 140 | A | $0 | 140(2) | I | By IRA | |
| Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Restricted Share Units P | (3) | 06/17/2026 | J | V | 2,164 | (4) | (4) | Series A Preference Shares | 2,164 | $0 | 2,164 | D | |||
| Share Appreciation Rights A | $13.03 | (5) | 05/01/2028 | Class A Common Shares | 15,170(6) | 15,170 | D | ||||||||
| Share Appreciation Rights C | $12.41 | (5) | 05/01/2028 | Class C Common Shares | 31,190(7) | 31,190 | D | ||||||||
| Share Appreciation Rights A | $13.93 | (5) | 05/01/2029 | Class A Common Shares | 14,847(8) | 14,847 | D | ||||||||
| Share Appreciation Rights C | $13.63 | (5) | 05/01/2029 | Class C Common Shares | 30,526(9) | 30,526 | D | ||||||||
| Share Appreciation Rights A | $7.29 | (5) | 03/16/2030 | Class A Common Shares | 26,709(10) | 26,709 | D | ||||||||
| Share Appreciation Rights C | $7.13 | (5) | 03/16/2030 | Class C Common Shares | 54,913(11) | 54,913 | D | ||||||||
| Share Appreciation Rights A | $9.8 | (5) | 03/16/2031 | Class A Common Shares | 47,666(12) | 47,666 | D | ||||||||
| Share Appreciation Rights C | $9.6 | (5) | 03/16/2031 | Class C Common Shares | 98,000(13) | 98,000 | D | ||||||||
| Share Appreciation Rights A | $9.8 | (5) | 03/16/2031 | Class A Common Shares | 23,699(14) | 23,699 | D | ||||||||
| Share Appreciation Rights C | $9.6 | (5) | 03/16/2031 | Class C Common Shares | 48,724(15) | 48,724 | D | ||||||||
| Share Appreciation Rights A | $6.78 | (5) | 03/11/2032 | Class A Common Shares | 36,386(16) | 36,386 | D | ||||||||
| Share Appreciation Rights C | $6.56 | (5) | 03/11/2032 | Class C Common Shares | 74,808(17) | 74,808 | D | ||||||||
| Share Appreciation Rights A | $5.47 | (5) | 03/20/2033 | Class A Common Shares | 23,626(18) | 23,626 | D | ||||||||
| Share Appreciation Rights C | $5.3 | (5) | 03/20/2033 | Class C Common Shares | 48,574(19) | 48,574 | D | ||||||||
| Share Appreciation Rights A | $4.31 | (20) | 03/12/2034 | Class A Common Shares | 29,303(21) | 29,303 | D | ||||||||
| Share Appreciation Rights C | $4.24 | (20) | 03/12/2034 | Class C Common Shares | 60,246(22) | 60,246 | D | ||||||||
| Share Appreciation Rights A | $4.68 | (23) | 03/14/2035 | Class A Common Shares | 27,082(24) | 27,082 | D | ||||||||
| Share Appreciation Rights C | $4.54 | (23) | 03/14/2035 | Class C Common Shares | 55,682(25) | 55,682 | D | ||||||||
| Share Appreciation Rights A | $5.31 | (26) | 03/13/2036 | Class A Common Shares | 23,978(27) | 23,978 | D | ||||||||
| Share Appreciation Rights C | $5.29 | (26) | 03/13/2036 | Class C Common Shares | 49,297(28) | 49,297 | D | ||||||||
| Explanation of Responses: |
| 1. On May 21, 2026, the Issuer announced that an authorized committee of the Issuer's board of directors declared a special dividend on each of its outstanding common shares payable on June 16, 2026 to all holders of record as of 5:00 p.m., New York City time, on June 1, 2026 consisting of a special dividend of 0.10 shares of newly issued 9.0% Fixed Rate Cumulative Perpetual Redeemable Series A Preferred Shares (the "Preferred Shares"), having an initial liquidation price of $25 per Preferred Share (the "Dividend"). As a result of the Dividend, the reporting person directly received 4,918 Preferred Shares. |
| 2. As a result of the Dividend, the reporting person directly received 140 Preferred Shares in his IRA account. |
| 3. Each Restricted Share Unit P ("RSU") represents a right to receive one share of the Issuer's Series A Preference Shares at settlement. |
| 4. The RSUs vest in full on March 15, 2027. |
| 5. The derivative security is fully vested. |
| 6. This share appreciation right award ("SAR") was previously reported as a SAR relating to 10,609 shares of the Issuer's common stock at a base price of $18.63 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| 7. This SAR was previously reported as a SAR relating to 21,218 shares of the Issuer's common stock at a base price of $18.24 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| 8. This SAR was previously reported as a SAR relating to 10,383 shares of the Issuer's common stock at a base price of $19.91 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| 9. This SAR was previously reported as a SAR relating to 20,766 shares of the Issuer's common stock at a base price of $20.03 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| 10. This SAR was previously reported as a SAR relating to 18,678 shares of the Issuer's common stock at a base price of $10.42 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| 11. This SAR was previously reported as a SAR relating to 37,356 shares of the Issuer's common stock at a base price of $10.48 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| 12. This SAR was previously reported as a SAR relating to 33,333 shares of the Issuer's common stock at a base price of $14.00 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| 13. This SAR was previously reported as a SAR relating to 66,667 shares of the Issuer's common stock at a base price of $14.10 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| 14. This SAR was previously reported as a SAR relating to 16,573 shares of the Issuer's common stock at a base price of $14.00 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| 15. This SAR was previously reported as a SAR relating to 33,146 shares of the Issuer's common stock at a base price of $14.10 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| 16. This SAR was previously reported as a SAR relating to 25,445 shares of the Issuer's common stock at a base price of $9.69 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| 17. This SAR was previously reported as a SAR relating to 50,890 shares of the Issuer's common stock at a base price of $9.63 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| 18. This SAR was previously reported as a SAR relating to 16,522 shares of the Issuer's common stock at a base price of $7.81 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| 19. This SAR was previously reported as a SAR relating to 33,044 shares of the Issuer's common stock at a base price of $7.78 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| 20. The SARs vest in full on March 15 2027. |
| 21. This SAR was previously reported as a SAR relating to 20,492 shares of the Issuer's common stock at a base price of $6.16 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| 22. This SAR was previously reported as a SAR relating to 40,984 shares of the Issuer's common stock at a base price of $6.22 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| 23. The SARs vest in two equal annual installments on March 15 of 2027 and 2028. |
| 24. This SAR was previously reported as a SAR relating to 18,939 shares of the Issuer's common stock at a base price of $6.69 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| 25. This SAR was previously reported as a SAR relating to 37,879 shares of the Issuer's common stock at a base price of $6.66 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| 26. The Share Appreciation Rights vest in three equal annual installments on March 15 of 2027, 2028 and 2029. |
| 27. This SAR was previously reported as a SAR relating to 16,768 shares of the Issuer's common stock at a base price of $7.58 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| 28. This SAR was previously reported as a SAR relating to 33,536 shares of the Issuer's common stock at a base price of $7.77 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| Remarks: |
| The trading symbols for the Issuer's classes of common shares are LILA, LILAB, and LILAK, and the trading symbol for the Issuer's Series A Preference Shares is LILAP. |
| /s/ John M. Winter, Attorney-in-Fact | 07/17/2026 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||
| * Form 4: SEC 1474 (03-26) | ||